News | January 31, 2008

Heart Disease Ranked Most Expensive of Top 10 Health Conditions

February 4, 2008 - Heart conditions cost $76 billion to treat in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

The nation’s 10 most expensive medical conditions costs totaled an estimated $500 billion to treat in 2005, said the survey. This includes money paid for visits to doctor's offices, clinics and emergency departments, hospital stays, home health care and prescription medicines.

Estimated spending for the 10 most expensive conditions:
1. Heart conditions $76 billion
2. Trauma disorders $72 billion
3. Cancer $70 billion
4. Mental disorders, including depression $56.0 billion
5. Asthma and chronic obstructive pulmonary disease $54 billion
6. High blood pressure $42 billion
7. Type 2 diabetes $34 billion
8. Osteoarthritis and other joint diseases $34 billion
9. Back problems $32 billion
10.Normal childbirth $32 billion

AHRQ, which is part of the U.S. Department of Health and Human Services, works to enhance the quality, safety, efficiency and effectiveness of health care in the United States. The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey, a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services and how they are paid.

For more information: www.ahrq.org


Related Content

News | Cardiovascular Clinical Studies

May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...

Home May 15, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health’s Karen Johnston, MD, has provided doctors with ...

Home May 14, 2024
Home
News | Cardiovascular Clinical Studies

May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms ...

Home May 13, 2024
Home
News | Cardiovascular Clinical Studies

May 13, 2024 — Even though mortality and hospitalization rates have improved, the quality of life for those living with ...

Home May 13, 2024
Home
News | Cardiovascular Clinical Studies

May 10, 2024 — Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which ...

Home May 10, 2024
Home
News | Cardiovascular Clinical Studies

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

Home May 02, 2024
Home
News | Cardiovascular Clinical Studies

May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...

Home May 01, 2024
Home
News | Cardiovascular Clinical Studies

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

Home April 30, 2024
Home
Subscribe Now